These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 12851277

  • 1. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW, Brook RH, Keeler E, Mangione CM.
    JAMA; 2003 Jul 09; 290(2):222-7. PubMed ID: 12851277
    [Abstract] [Full Text] [Related]

  • 2. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM.
    JAMA; 2004 Aug 25; 292(8):952-60. PubMed ID: 15328327
    [Abstract] [Full Text] [Related]

  • 3. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF, Escarce JJ, Solomon MD, Goldman DP.
    JAMA; 2002 Oct 09; 288(14):1733-9. PubMed ID: 12365957
    [Abstract] [Full Text] [Related]

  • 4. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
    Yeung K, Barthold D, Dusetzina SB, Basu A.
    N Engl J Med; 2020 Aug 06; 383(6):558-566. PubMed ID: 32757524
    [Abstract] [Full Text] [Related]

  • 5. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.
    Arch Gen Psychiatry; 2005 Apr 06; 62(4):435-41. PubMed ID: 15809411
    [Abstract] [Full Text] [Related]

  • 6. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C.
    EBRI Issue Brief; 1999 Apr 06; (208):1-21. PubMed ID: 10539445
    [Abstract] [Full Text] [Related]

  • 7. Unintended consequences of caps on Medicare drug benefits.
    Hsu J, Price M, Huang J, Brand R, Fung V, Hui R, Fireman B, Newhouse JP, Selby JV.
    N Engl J Med; 2006 Jun 01; 354(22):2349-59. PubMed ID: 16738271
    [Abstract] [Full Text] [Related]

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM, Urmie JM, Farris KB, Doucette WR.
    Res Social Adm Pharm; 2010 Jun 01; 6(2):100-9. PubMed ID: 20511109
    [Abstract] [Full Text] [Related]

  • 9. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?
    Tjia J, Schwartz JS.
    J Am Geriatr Soc; 2006 Apr 01; 54(4):606-12. PubMed ID: 16686870
    [Abstract] [Full Text] [Related]

  • 10. Medicare beneficiaries' management of capped prescription benefits.
    Cox ER, Jernigan C, Coons SJ, Draugalis JL.
    Med Care; 2001 Mar 01; 39(3):296-301. PubMed ID: 11242323
    [Abstract] [Full Text] [Related]

  • 11. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI, Rascati KL.
    Arthritis Care Res (Hoboken); 2012 Sep 01; 64(9):1423-9. PubMed ID: 22508663
    [Abstract] [Full Text] [Related]

  • 12. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD, Davis MM.
    J Am Soc Nephrol; 2006 Sep 01; 17(9):2546-53. PubMed ID: 16855016
    [Abstract] [Full Text] [Related]

  • 13. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H, Adamson A, Mostaghimi A.
    JAMA Dermatol; 2017 Aug 01; 153(8):755-759. PubMed ID: 28453645
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C, Regan S, Henault LE, Hylek EM, Schwartz GR.
    J Am Geriatr Soc; 2007 Jul 01; 55(7):1038-43. PubMed ID: 17608876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ, Alecxih L, Gibson MJ, Corea J, Caplan C, Brangan N.
    Health Serv Res; 1999 Apr 01; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [Abstract] [Full Text] [Related]

  • 19. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA, Rogowski J, Kington R.
    Med Care; 1999 Sep 01; 37(9):926-36. PubMed ID: 10493470
    [Abstract] [Full Text] [Related]

  • 20. Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health.
    Saver BG, Doescher MP, Jackson JE, Fishman P.
    Value Health; 2004 Sep 01; 7(2):133-43. PubMed ID: 15164803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.